[{"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090355"], "brand_name": ["THEOPHYLLINE"], "generic_name": ["THEOPHYLLINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-356", "68462-380"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["THEOPHYLLINE ANHYDROUS"], "rxcui": ["313291", "348472"], "spl_id": ["aaa6684e-4eef-42a8-92b6-8f317e570903"], "spl_set_id": ["56fc2167-ceb6-4e3e-8ff7-5e400dfbd533"], "package_ndc": ["68462-380-01", "68462-380-05", "68462-356-01", "68462-356-05"], "is_original_packager": [true], "upc": ["0368462380017", "0368462356012"], "nui": ["N0000175790", "M0023046"], "pharm_class_epc": ["Methylxanthine [EPC]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["0I55128JYK"]}, "product_type": "Drugs", "event_id": "97406", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0583-2025", "product_description": "Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa- 403513 India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ, NDC 68462-380-01", "product_quantity": "22,656 bottles", "reason_for_recall": "Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.", "recall_initiation_date": "20250808", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Batch # 19243193, 19243215, 19243231,19243248, 19243283, Exp 7/31/2026; 19244530, 19244561, Exp 10/31/2026; 19250178, Exp 12/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Bryan", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97053", "recalling_firm": "Nostrum Laboratories, Inc.", "address_1": "705 E Mulberry St", "address_2": "", "postal_code": "43506-1432", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide within the United States", "recall_number": "D-0547-2025", "product_description": "Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) 500-count bottles, NDC 29033-0003-05), Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120.", "product_quantity": "60,608 bottles", "reason_for_recall": "CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.", "recall_initiation_date": "20250711", "center_classification_date": "20250731", "report_date": "20250806", "code_info": "All Lots within expiry dates.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0669-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-029-01", "product_quantity": "3,384 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250158A, Exp Date: 06-22-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2"], "spl_set_id": ["aa086a21-de85-4b03-af58-49b70acf8cf0"], "package_ndc": ["69238-1054-1", "69238-1056-1", "69238-1058-1", "69238-1060-1", "69238-1062-1"], "is_original_packager": [true], "upc": ["0369238105612", "0369238106213"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97438", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0617-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1058-1.", "product_quantity": "13,130 100-count bottles", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was   detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250818", "center_classification_date": "20250904", "report_date": "20250910", "code_info": "Lot: AM240147, AM240148, Exp Date 01/31/2027; Lot AM240664,  AM240665, Exp Date 04/30/2027."}, {"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214331"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-306", "36000-372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["483017", "2715604"], "spl_id": ["8656ca5b-eba7-4812-b423-aab2ee0a16de"], "spl_set_id": ["0f67c1bd-915b-4681-88dd-22f5154a80b3"], "package_ndc": ["36000-306-60", "36000-372-40"], "is_original_packager": [true], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "97453", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0596-2025", "product_description": "Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60.", "product_quantity": "13,000 containers", "reason_for_recall": "Discoloration", "recall_initiation_date": "20250820", "center_classification_date": "20250822", "report_date": "20250903", "code_info": "Lot #: 24A27G66, Exp 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97370", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0577-2025", "product_description": "Carvedilol Tablets, USP, 3.125 mg, Packaged as: a)500-count bottle, NDC 68462-162-05; b) 100-count bottle, NDC 68462-162-01; Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India.  Manufactured for Glenmark Pharmaceuticals, Inc., Mahwah, NJ, USA, NJ 07430.", "product_quantity": "44,328 bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine,  N-Nitroso Carvedilol I  Impurity above the current Acceptable Intake Level.", "recall_initiation_date": "20250807", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Lot#: a)19242274, 19242275, 19242272, Exp: 5/31/20; b) 19242272, Exp: 5/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0520-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 90-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-448-15", "product_quantity": "54,227 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300087, Exp Date: 12/31/2025"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0479-2025", "product_description": "Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "32 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot #: H270221, Exp 12/26/2025", "more_code_info": ""}, {"status": "Completed", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA214609"], "brand_name": ["VENLAFAXINE"], "generic_name": ["VENLAFAXINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc."], "product_ndc": ["43598-943", "43598-944"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["808744", "808748"], "spl_id": ["79d34297-6604-4031-a89a-8ec557d078d1"], "spl_set_id": ["9312f4df-63d9-4167-880f-36a816870442"], "package_ndc": ["43598-943-30", "43598-943-90", "43598-944-30", "43598-944-90"], "is_original_packager": [true], "upc": ["0343598943909", "0343598944906", "0343598944302", "0343598943305"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "96128", "recalling_firm": "Appco Pharma LLC", "address_1": "262 Old New Brunswick Rd Unit N", "address_2": "", "postal_code": "08854-3756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA.", "recall_number": "D-0208-2025", "product_description": "Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.", "product_quantity": "1380 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet", "recall_initiation_date": "20250116", "center_classification_date": "20250123", "report_date": "20250129", "code_info": "Lot #: 2402101UR, Exp 02/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["MAXIMUM SECURITY"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-132"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["067a1e13-c34a-42b0-a16e-a343ff84bf91"], "spl_set_id": ["a89160b6-a204-46c7-8719-bb9c9ed6fe8a"], "package_ndc": ["53247-132-01", "53247-132-02", "53247-132-03", "53247-132-04", "53247-132-05"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0432-2025", "product_description": "Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 0.85 oz (24 g) Tube, Made in India, Dist. by Bob Barker Co. Inc. Fuquay-Varnia, NC 27526, NDC 53247-132-03", "product_quantity": "615, 600 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0008, B0009, B0017, Exp Date: 05/31/2026; Lot B0042, B0043, B0044, Exp Date: 06/30/2026; Lot B0049, B0050, B0051, B0054, B0058, B0059, Exp Date: 07/31/2026; Lot B0061, B0062, B0063, B0064, B0065, B0068, B0069, Exp Date: 08/31/2026"}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96380", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0271-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-746-05", "product_quantity": "11,125 bottles.", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250228", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot#: 240098C, Expiration: 01/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202097"], "brand_name": ["FENTANYL SYSTEM"], "generic_name": ["FENTANYL"], "manufacturer_name": ["ALVOGEN"], "product_ndc": ["47781-423", "47781-424", "47781-426", "47781-427", "47781-428"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["FENTANYL"], "rxcui": ["197696", "245134", "245135", "245136", "577057"], "spl_id": ["25508d17-4c96-00d3-e063-6294a90a3222"], "spl_set_id": ["242759ef-cb6d-4e3e-9f8d-5e31efa1f289"], "package_ndc": ["47781-423-11", "47781-423-47", "47781-424-11", "47781-424-47", "47781-426-11", "47781-426-47", "47781-427-11", "47781-427-47", "47781-428-11", "47781-428-47"], "is_original_packager": [true], "nui": ["N0000175684", "N0000175690"], "pharm_class_moa": ["Full Opioid Agonists [MoA]"], "pharm_class_epc": ["Opioid Agonist [EPC]"], "unii": ["UF599785JZ"]}, "product_type": "Drugs", "event_id": "96222", "recalling_firm": "Alvogen, Inc", "address_1": "44 Whippany Rd Ste 300", "address_2": "N/A", "postal_code": "07960-4558", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0245-2025", "product_description": "Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.", "product_quantity": "112,128 cartons (5 pouches/carton)", "reason_for_recall": "Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.", "recall_initiation_date": "20250131", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot #: 108319, Exp: 04/30/2027"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA088108"], "brand_name": ["METHADONE HYDROCHLORIDE"], "generic_name": ["METHADONE HYDROCHLORIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0054-0709", "0054-0710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHADONE HYDROCHLORIDE"], "rxcui": ["864706", "864718"], "spl_id": ["b1ede48e-d72f-4dcc-a804-453378c1f165"], "spl_set_id": ["50f14803-78c0-4d19-8b5d-9a9c17582ac1"], "package_ndc": ["0054-0709-25", "0054-0709-20", "0054-0710-25", "0054-0710-20"], "is_original_packager": [true], "upc": ["0300540709259", "0300540710255"], "unii": ["229809935B"]}, "product_type": "Drugs", "event_id": "95999", "recalling_firm": "West-Ward Columbus Inc", "address_1": "1809 Wilson Rd", "address_2": "", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0183-2025", "product_description": "Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0709-20", "product_quantity": "2591 100-count boxes", "reason_for_recall": "Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.", "recall_initiation_date": "20241219", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot # AC2556A; Exp. 03/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078761"], "brand_name": ["MORPHINE SULFATE"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-450", "63304-451", "63304-758", "63304-452", "63304-453"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["891874", "891881", "891888", "891893", "892646"], "spl_id": ["39a0166a-c2ca-47bf-8654-85e0a431b9a0"], "spl_set_id": ["736c9b80-682c-4cda-bf18-61b18de0bd39"], "package_ndc": ["63304-450-03", "63304-450-01", "63304-450-05", "63304-451-03", "63304-451-01", "63304-451-05", "63304-758-03", "63304-758-01", "63304-758-05", "63304-758-50", "63304-452-03", "63304-452-01", "63304-452-05", "63304-453-03", "63304-453-01", "63304-453-05"], "is_original_packager": [true], "upc": ["0363304453010", "0363304758016", "0363304452013", "0363304450019", "0363304451016"], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "96242", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within in the USA.", "recall_number": "D-0249-2025", "product_description": "Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901.  Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512.  NDC 63304-452-01", "product_quantity": "9840 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250206", "center_classification_date": "20250303", "report_date": "20250312", "code_info": "Lot #: AD16615, Exp. Date 07/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212824"], "brand_name": ["MEDROXYPROGESTERONE ACETATE"], "generic_name": ["MEDROXYPROGESTERONE ACETATE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-329", "55150-330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["MEDROXYPROGESTERONE ACETATE"], "rxcui": ["1000126", "1000153"], "spl_id": ["7f75e36b-db42-43ef-b81f-c7c97948b2f5"], "spl_set_id": ["0655670a-d127-4e08-8a23-ace64b2503b2"], "package_ndc": ["55150-329-01", "55150-329-25", "55150-330-01"], "is_original_packager": [true], "upc": ["0355150330010", "0355150329014"], "unii": ["C2QI4IOI2G"]}, "product_type": "Drugs", "event_id": "96018", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0185-2025", "product_description": "medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01  Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India", "product_quantity": "19872 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20241218", "center_classification_date": "20250106", "report_date": "20250115", "code_info": "Lot No.: 1MP24069, Exp.: 08/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076109"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-1003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["KETOROLAC TROMETHAMINE"], "spl_id": ["fb740a51-5459-3c22-949d-7e4c9142fe84"], "spl_set_id": ["d9a186ba-74a9-b6d4-1109-1e045ba1763e"], "package_ndc": ["60505-1003-1", "60505-1003-2", "6050510031", "3605051003"], "is_original_packager": [true], "unii": ["4EVE5946BQ"], "upc": ["360505100316"]}, "product_type": "Drugs", "event_id": "97561", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0677-2025", "product_description": "Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.", "product_quantity": "493,468 bottles", "reason_for_recall": "Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns", "recall_initiation_date": "20250905", "center_classification_date": "20250930", "report_date": "20251008", "code_info": "Batch # VA0444, exp. date 01/2026 Batch # VA4608, exp. date 01/2026 Batch # TZ7016, exp. date 12/2025  UPC on Bottles: (01)0(03)60505100316 UPC on Cartons: 360505100316"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96607", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "N/A", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0371-2025", "product_description": "dexmedeTOMIDine HCl PF, in 0.9% Sodium Chloride, 20 mcg (base) per 5mL, (4 mcg (base) per mL), 5mL Single Dose syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112, NDC: 71449-131-11.", "product_quantity": "23,610 syringes", "reason_for_recall": "Lack of Assurance of Sterility: Leaking/damaged syringes.", "recall_initiation_date": "20250331", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #: 2431276A, Exp.: 4/20/2025"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0243-2025", "product_description": "Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-760-01.", "product_quantity": "58,416 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233234, 19233253, Exp.: 7/2025; 19234154, Exp.: 9/2025; 19243185, Exp.: 7/2026; 19243951, 19243974, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0671-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01", "product_quantity": "9,917 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250178A, Exp Date: 06-22-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0261-2025", "product_description": "Alprostadil   Container Description: Amber color bottle", "product_quantity": "3.0 gm", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HAALC0020922 exp. date AUG-2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96996", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0499-2025", "product_description": "BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL Sterile Single-Dose Vial, Rx Only, For Nerve Block, Caudal & Epidural Anesthesia Only, Warning: Contains Sulfites, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0036-0.", "product_quantity": "975 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.", "recall_initiation_date": "20250602", "center_classification_date": "20250630", "report_date": "20250709", "code_info": "Lot #s: 2502005, Exp. 2/20/26; 2502006, Exp 2/23/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Wuxi", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96210", "recalling_firm": "Wuxi Medical lnstrument Factory Co., Ltd.", "address_1": "D, Zhangjing", "address_2": "No. 43 Xixin Road; Xibeizhen Xishan", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0247-2025", "product_description": "ViaMed Alcohol Prep Pads, For External Use Only, 70% Isopropyl Alcohol, Sterile, 100 pieces per Box, 100 boxes per Carton, Sterile, Manufactured by Wuxi Medical Instrument Factory Co., Ltd., Made in China, Manufactured for: Rece International Corp., Miami Lakes, FL, 33014, USA, NDC: 70006-500-01.", "product_quantity": "37,500 Boxes", "reason_for_recall": "Lack of assurance of sterility and cGMP deviations observed at the manufacturing site.", "recall_initiation_date": "20250212", "center_classification_date": "20250221", "report_date": "20250305", "code_info": "Lot #s: 200830, Exp 08/29/2025; 210925, Exp 09/24/2026; 221225, Exp 12/24/2027."}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96380", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0270-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10", "product_quantity": "14,749 bottles.", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250228", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot#: 240225C, Expiration: 01/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96446", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0295-2025", "product_description": "fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478.  NDC: 70092-1255-75", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250306", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lots: 10140259, 10140539, 10140687, 10140688; Exp 04/24/2025"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0475-2025", "product_description": "CJC-1295 Injectable, 6mg/15mg, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "60 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot#: H261968, Exp 12/23/2025; H261358, Exp 5/13/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-195", "68462-196", "68462-197", "68462-198"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["a6e006b3-4256-4cbb-8ad1-b71f363430cd"], "spl_set_id": ["6ca01de3-a0f9-4cfb-b36a-723c7c42e2a4"], "package_ndc": ["68462-195-90", "68462-195-05", "68462-196-90", "68462-196-05", "68462-197-90", "68462-197-05", "68462-198-90", "68462-198-05"], "is_original_packager": [true], "upc": ["0368462195901", "0368462198902"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0325-2025", "product_description": "Pravastatin Sodium Tablets 80mg, 90-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-198-90.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17221771, exp. date Aug-25 17230930, exp. date Apr-26 17230931, exp. date Apr-26 17231252, exp. date May-26 17231274, exp. date May-26 17231855, exp. date Aug-26 17231916, exp. date Aug-26 17231917, exp. date Aug-26 17231945, exp. date Aug-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212144"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-861", "68462-862", "68462-863", "68462-864", "68462-865"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["440a4208-83cc-4ffa-952c-d9c0745c342a"], "spl_set_id": ["a6065ac5-a111-449b-b51b-8bc2907d1ddb"], "package_ndc": ["68462-861-01", "68462-861-10", "68462-862-01", "68462-862-10", "68462-863-01", "68462-863-10", "68462-864-01", "68462-864-10", "68462-865-01", "68462-865-10"], "is_original_packager": [true], "upc": ["0368462862018", "0368462864012", "0368462863015", "0368462861011"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "95936", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0160-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01", "product_quantity": "", "reason_for_recall": "CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20241211", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot#: 17230133, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "97031", "recalling_firm": "Church & Dwight Inc", "address_1": "469 N Harrison St", "address_2": "", "postal_code": "08540-3510", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0504-2025", "product_description": "ZICAM COLD REMEDY MEDICATED NASAL SWABS, 20 Single-Use Swabs per carton, Distributed by Church & Dwight Co,. Inc., Ewing NJ. UPC 7 32216 30120 5", "product_quantity": "3,374,918 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.", "recall_initiation_date": "20250606", "center_classification_date": "20250703", "report_date": "20250709", "code_info": "All lots.", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209745"], "brand_name": ["SILODOSIN"], "generic_name": ["SILODOSIN"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-777", "42291-778"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SILODOSIN"], "rxcui": ["809477", "826612"], "spl_id": ["0e9abeed-2337-d18a-e063-6394a90a4127"], "spl_set_id": ["ea3bbafb-d32a-d0d3-e053-2a95a90ac387"], "package_ndc": ["42291-777-30", "42291-778-90"], "is_original_packager": [true], "nui": ["N0000000099", "N0000175553"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]"], "unii": ["CUZ39LUY82"]}, "product_type": "Drugs", "event_id": "96247", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0229-2025", "product_description": "Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90", "product_quantity": "1266 bottles", "reason_for_recall": "Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)", "recall_initiation_date": "20250204", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot#: BC20223A, Exp. March 31, 2025."}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA050141"], "brand_name": ["BICILLIN L-A"], "generic_name": ["PENICILLIN G BENZATHINE"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-700", "60793-701", "60793-702"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["PENICILLIN G BENZATHINE"], "rxcui": ["731564", "731566", "731567", "731568", "731570", "731571"], "spl_id": ["4b3694af-9d77-487f-8838-b75aec6636da"], "spl_set_id": ["012d46f1-d0a0-4676-a879-cd320297ab16"], "package_ndc": ["60793-700-01", "60793-700-10", "60793-701-02", "60793-701-10", "60793-702-04", "60793-702-10"], "is_original_packager": [true], "unii": ["RIT82F58GK"]}, "product_type": "Drugs", "event_id": "97220", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0544-2025", "product_description": "Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC -  60793-701-10, Syringe NDC - 60793-701-02", "product_quantity": "50,855 2 mL vials", "reason_for_recall": "CGMP Deviations; particulates identified during visual inspection", "recall_initiation_date": "20250710", "center_classification_date": "20250730", "report_date": "20250806", "code_info": "Lots: HJ3235, Exp 09/30/26;  GL2954, HP6222,  Exp, 01/31/27; HR9967, Exp 05/31/27; HP6232, LT5190,Exp 09/30/27; HP6228, Exp 10/31/27;", "more_code_info": ""}, {"status": "Ongoing", "city": "Collegeville", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96121", "recalling_firm": "Provepharm Inc.", "address_1": "100 Springhouse Dr Ste 105", "address_2": "N/A", "postal_code": "19426-4709", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0230-2025", "product_description": "Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as a single unit), Dist. by: Provepharm, Inc., Collegeville, PA 19426", "product_quantity": "24640 vials", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20250121", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot#  24020027, Exp Date: 12/31/2025"}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021269"], "brand_name": ["CARDURA"], "generic_name": ["DOXAZOSIN MESYLATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["58151-078", "58151-079"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXAZOSIN MESYLATE"], "rxcui": ["636360", "636361", "1242404", "1242408"], "spl_id": ["7fe31b0a-4fb2-427f-83e2-d5b957d6738b"], "spl_set_id": ["355bcdce-0481-48ba-8ebd-2009106aaf77"], "package_ndc": ["58151-078-93", "58151-079-93"], "is_original_packager": [true], "upc": ["0358151078936"], "unii": ["86P6PQK0MU"]}, "product_type": "Drugs", "event_id": "96036", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0203-2025", "product_description": "Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93", "product_quantity": "1,215/30 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.", "recall_initiation_date": "20241223", "center_classification_date": "20250116", "termination_date": "20251112", "report_date": "20250122", "code_info": "Lot # 8181625, Exp 12/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96419", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0257-2025", "product_description": "Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50", "product_quantity": "4,190 bottles", "reason_for_recall": "Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.", "recall_initiation_date": "20250210", "center_classification_date": "20250307", "termination_date": "20250814", "report_date": "20250319", "code_info": "Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078203"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6007", "0904-6008", "0904-6009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LORAZEPAM"], "rxcui": ["197900", "197901", "197902"], "spl_id": ["6b6c2fbc-d12d-41d7-b49d-cf374c773cbd"], "spl_set_id": ["62f6eb3b-813d-4890-aca9-799b7fa890df"], "package_ndc": ["0904-6007-60", "0904-6007-61", "0904-6008-60", "0904-6008-61", "0904-6009-60", "0904-6009-61"], "original_packager_product_ndc": ["69315-904", "69315-905", "69315-906"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "96151", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide U.S. and Puerto rico", "recall_number": "D-0227-2025", "product_description": "Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-905 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6008-61.", "product_quantity": "94,349 cartons", "reason_for_recall": "Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.", "recall_initiation_date": "20250121", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot #s: N01419, N01420, N01421, Exp 03/31/2025; N01663, Exp 06/30/2025; N01664, Exp 08/31/2025; N01673, Exp 09/30/2025; N01688, Exp 08/31/2025; N01747, N01748, N01749, Exp 11/30/2025; N01792, Exp 12/31/2025; N01857, Exp 02/28/2026; N01974, Exp 05/31/2026; N02081, Exp 08/31/2026."}, {"status": "Ongoing", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761070"], "brand_name": ["FASENRA"], "generic_name": ["BENRALIZUMAB"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-1730", "0310-1830", "0310-1745"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["BENRALIZUMAB"], "rxcui": ["1989104", "1989109", "2205632", "2205634", "2679499", "2679502"], "spl_id": ["901977cc-c730-4b8b-9faf-ca24afc3589a"], "spl_set_id": ["da6aca1a-19ed-44a4-abb7-696c7d58b784"], "package_ndc": ["0310-1730-30", "0310-1730-85", "0310-1830-30", "0310-1830-85", "0310-1745-01", "0310-1745-95"], "is_original_packager": [true], "nui": ["N0000193803", "N0000193802"], "pharm_class_epc": ["Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]"], "unii": ["71492GE1FX"]}, "product_type": "Drugs", "event_id": "97760", "recalling_firm": "ASTRAZENECA PHARMACEUTICALS", "address_1": "950 Wind River Ln", "address_2": "", "postal_code": "20878-1974", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0028-2026", "product_description": "Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30", "product_quantity": "916 pre-filled syringes", "reason_for_recall": "Lack of Assurance of Sterility:", "recall_initiation_date": "20251008", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot YJ0152, Expiry: 01/31/2028.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0233-2025", "product_description": "Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-267-30.", "product_quantity": "175,920 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233792, Exp.: 8/2025; 19233795, Exp.: 8/2025; 19234258, Exp.: 9/2025; 19240912, Exp.: 2/2026; 19241476, 19241477, Exp.: 3/2026; 19242599, Exp.: 6/2026; 19243163, 19243162, Exp.:7/2026;19243884, 19243887, Exp.:9/2026."}, {"status": "Ongoing", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96853", "recalling_firm": "KABANA SKIN CARE", "address_1": "685 S Arthur Ave Unit 9b", "address_2": "N/A", "postal_code": "80027-3141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, FL, MI", "recall_number": "D-0512-2025", "product_description": "B Natural Organics, Organic Sunscreen, Broad Spectrum, SPF 30, 25% non-nano Zinc Oxide, a) Nude Tint Mineral Formula for Face and Body, 4 oz. (120 ML) per bottle. NDC: 73369-1002-2; b) Tint Free Mineral Formula for Face and Body, 4 oz. (120 ML) per bottle. NDC:  73369-1001-2; c) Tan Tint Mineral Formula for Face and Body, 4 oz. (120 ML) per bottle. NDC: 73369-1003-2.", "product_quantity": "204 tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250312", "center_classification_date": "20250710", "report_date": "20250716", "code_info": "Lots: a) 410-001, Exp 10/31/2027 b) 404-003, Exp 04/30/2027 c) 404-001, Exp 04/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96996", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0498-2025", "product_description": "LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative-Free, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0000-0.", "product_quantity": "29,700 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.", "recall_initiation_date": "20250602", "center_classification_date": "20250630", "report_date": "20250709", "code_info": "Lot #s: 2502004, Exp. 2/18/27; 2503003, Exp. 3/19/27", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215236"], "brand_name": ["GENTAMICIN"], "generic_name": ["GENTAMICIN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-401"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["GENTAMICIN SULFATE"], "rxcui": ["1870676"], "spl_id": ["f8c608b3-50b8-4d5d-9e8a-e92c0d2e3cdc"], "spl_set_id": ["f8c608b3-50b8-4d5d-9e8a-e92c0d2e3cdc"], "package_ndc": ["55150-401-01", "55150-401-25"], "is_original_packager": [true], "upc": ["0355150401017"], "unii": ["8X7386QRLV"]}, "product_type": "Drugs", "event_id": "96976", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0472-2025", "product_description": "Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25", "product_quantity": "48,000 vials", "reason_for_recall": "Failed Stability Specifications:  Out of specification results for the Color Absorbance test during 12 Month sample analysis.", "recall_initiation_date": "20250529", "center_classification_date": "20250618", "report_date": "20250625", "code_info": "Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Panchmahal", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA204519"], "brand_name": ["CELECOXIB"], "generic_name": ["CELECOXIB"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-140", "62332-141", "62332-142", "62332-143"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CELECOXIB"], "rxcui": ["205322", "205323", "349514", "686379"], "spl_id": ["0ae26abe-bbc0-48bf-b038-ca400ee197cd"], "spl_set_id": ["806e5f8a-f986-4f88-ba3e-8265f86afa48"], "package_ndc": ["62332-140-30", "62332-140-60", "62332-140-91", "62332-140-08", "62332-141-30", "62332-141-31", "62332-141-91", "62332-141-08", "62332-141-60", "62332-141-71", "62332-142-30", "62332-142-31", "62332-142-91", "62332-142-71", "62332-142-08", "62332-142-60", "62332-143-30", "62332-143-60", "62332-143-71", "62332-143-10", "2405014780"], "is_original_packager": [true], "upc": ["0362332142309", "0362332143306", "0362332141302", "0362332140305"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["JCX84Q7J1L"]}, "product_type": "Drugs", "event_id": "96840", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide and in PR", "recall_number": "D-0459-2025", "product_description": "Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-142-71", "product_quantity": "2,946 500-count bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule", "recall_initiation_date": "20250509", "center_classification_date": "20250606", "report_date": "20250618", "code_info": "Batch 2405014780, Exp. Date: Sep. 30, 2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216916"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-780", "70010-781", "70010-782", "70010-783"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866412", "866419", "866427", "866436"], "spl_id": ["1c7ab139-2fb1-f011-e063-6394a90add6c"], "spl_set_id": ["ff180ca2-7490-a571-e053-6394a90a97b1"], "package_ndc": ["70010-780-01", "70010-780-05", "70010-780-10", "70010-781-01", "70010-781-05", "70010-781-10", "70010-782-01", "70010-782-05", "70010-782-10", "70010-783-01", "70010-783-05", "70010-783-10"], "is_original_packager": [true], "upc": ["0370010782013", "0370010783010", "0370010781016"], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "97131", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0510-2025", "product_description": "Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,", "product_quantity": "27,648 100-count Bottles; 5,376 500-count Bottles", "reason_for_recall": "Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25\u00bfC/60% RH) long-term.", "recall_initiation_date": "20250624", "center_classification_date": "20250708", "report_date": "20250709", "code_info": "Lot # a)1400008A, Exp Date: 12/31/2025; b) 1400008B, Exp Date: 12/31/2025", "more_code_info": ""}, {"status": "Completed", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203503"], "brand_name": ["VORICONAZOLE"], "generic_name": ["VORICONAZOLE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-273", "60687-294"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VORICONAZOLE"], "rxcui": ["349434", "349435"], "spl_id": ["3f173cc6-1846-9797-e063-6394a90ad8eb"], "spl_set_id": ["8379ac92-53cd-46db-8642-017f11830a86"], "package_ndc": ["60687-294-11", "60687-294-21", "60687-273-11", "60687-273-21"], "original_packager_product_ndc": ["68462-572", "68462-573"], "nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["JFU09I87TR"]}, "product_type": "Drugs", "event_id": "96574", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0307-2025", "product_description": "Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11.", "product_quantity": "889 cartons", "reason_for_recall": "cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.", "recall_initiation_date": "20250324", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot # 1014138, Exp 04/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206055"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-848", "68382-849"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM DIHYDRATE"], "rxcui": ["692576", "692578"], "spl_id": ["bc31956a-671b-4ca3-b9dd-1fdb03003cae"], "spl_set_id": ["190a4c5b-1547-45d7-b00b-10da4131e2e2"], "package_ndc": ["68382-848-94", "68382-849-94"], "is_original_packager": [true], "unii": ["36H71644EQ"]}, "product_type": "Drugs", "event_id": "96860", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide -in the USA", "recall_number": "D-0442-2025", "product_description": "Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94", "product_quantity": "30,674 30 sachets/carton", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.", "recall_initiation_date": "20250513", "center_classification_date": "20250520", "report_date": "20250528", "code_info": "Lot #  M311638, Exp 07/2025, M400374, Exp 10/2025, M402496, Exp 02/2026, M407998, Exp 05/2026, M502247, Exp 11/2026, M414770, M414512, Exp 09/2026."}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["MEDLINE ALCOHOL PREP"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-811"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["41483c3f-f207-027f-e063-6394a90aea68"], "spl_set_id": ["c9fae7b6-2f4b-490b-9b17-a7297e738069"], "package_ndc": ["53329-811-30", "53329-811-09", "6122404005"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "96404", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide", "recall_number": "D-0288-2025", "product_description": "Medline Alcohol Prep Pads, 70% Isopropyl Alcohol, 100 Sterile 2-Ply Pads, Single Use Only, Large, www.medline.com, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, 1-800-MEDLINE, NDC 53329-811-30.", "product_quantity": "6,669,874 pads", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250217", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "SKU: MDS090670, Lot: 61224040057"}, {"status": "Ongoing", "city": "Grand Prairie", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96465", "recalling_firm": "Fruit Of The Earth, Inc.", "address_1": "1430 Avenue R", "address_2": "N/A", "postal_code": "75050-1605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0283-2025", "product_description": "Walgreens Maximum Strength Tinted Acne Treatment Cream 10% Benzoyl Peroxide/Acne Medication, 0.65 oz (18.4g) tube in a carton; Distributed by: Walgreen CO., 200 Wilmot Rd., Deerfield, IL 60015", "product_quantity": "100,970 tubes", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20250311", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot #: 4970743B, 4970743C Exp 3/31/2026, 9722793A, Exp 9/30/2026; 8363513A, Exp 12/3/2026; 2822284A, Exp 8/31/2027; 2143554A, Exp 12/31/2027."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0342-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mg, 100-count bottle, Rx, Only. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-562-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17241067, exp. date May-26 17241628, exp. date Aug-26"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209718"], "brand_name": ["CLOBAZAM"], "generic_name": ["CLOBAZAM"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOBAZAM"], "rxcui": ["199450"], "spl_id": ["3d5d1f23-c639-3604-e063-6294a90ac606"], "spl_set_id": ["8fce3252-95f8-4428-9922-5ba308e20177"], "package_ndc": ["60687-423-11", "60687-423-21"], "original_packager_product_ndc": ["69238-1305"], "nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "unii": ["2MRO291B4U"]}, "product_type": "Drugs", "event_id": "96017", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0184-2025", "product_description": "Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-21", "product_quantity": "5,178 cartons", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20241213", "center_classification_date": "20250106", "report_date": "20250115", "code_info": "Lot #: 1019594, Exp. Date 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Manhattan", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97334", "recalling_firm": "Pfizer", "address_1": "66 Hudson Blvd", "address_2": "N/A", "postal_code": "10001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within U.S", "recall_number": "D-0575-2025", "product_description": "Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.", "product_quantity": "29, 004 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20250729", "center_classification_date": "20250808", "report_date": "20250820", "code_info": "Lot #: 24C11, Exp 2/28/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["MAXIMUM SECURITY"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-132"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["067a1e13-c34a-42b0-a16e-a343ff84bf91"], "spl_set_id": ["a89160b6-a204-46c7-8719-bb9c9ed6fe8a"], "package_ndc": ["53247-132-01", "53247-132-02", "53247-132-03", "53247-132-04", "53247-132-05"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0433-2025", "product_description": "Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 0.15 OZ (4.25 g) Sachets, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-01", "product_quantity": "1,559,000 Sachets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0010, B0017, Exp Date: 05/31/2026; Lot B0028, B0029, B0030, Exp Date: 06/30/2026; Lot B0052, Exp Date: 07/31/2026; Lot B0091, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0260-2025", "product_description": "Bimatoprost  NDC# 82187-1001-1  Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.", "product_quantity": "400.0 gm", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HABTC0020123, exp. date Dec-2026 HABTC0050623, exp. date May-2027 HABTC0091023, exp. date Sep-2028", "more_code_info": ""}, {"status": "Ongoing", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016733"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-2201"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["35e26a6d-60d6-4388-84e9-c481a3b69ee7"], "spl_set_id": ["0d59a04a-32e6-485b-b638-a1e6c09e9642"], "package_ndc": ["0264-2201-00", "0264-2201-10", "0264-2201-50", "0264-2201-70"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "96605", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 Mcgaw Ave", "address_2": "N/A", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 12 distributors who may have further distributed the product nationwide.", "recall_number": "D-0353-2025", "product_description": "0.9% Sodium chloride Irrigation USP, Isotonic Solution for Irrigation, 500 mL Plastic Irrigation Container (PIC), B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-2201-10", "product_quantity": "32,256 Bottles", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20250331", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # J4K936, Exp 7/31/2027"}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0561-2025", "product_description": "Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol,  Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "221 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96666", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide US.", "recall_number": "D-0397-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 90 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-452-15", "product_quantity": "18,984 Bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20250410", "center_classification_date": "20250430", "report_date": "20250507", "code_info": "Lot # D2400725, Exp Date: 03/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Kennett Square", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97202", "recalling_firm": "Boothwyn Pharmacy LLC", "address_1": "221 Gale Ln", "address_2": "N/A", "postal_code": "19348", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0606-2025", "product_description": "Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy", "product_quantity": "642 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250709", "center_classification_date": "20250829", "report_date": "20250910", "code_info": "03202025@5, 03202025@6, 03202025@7, 03202025@8 BUD 07/18/2025"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0012-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7132-61, UPC (01)00309047132614", "product_quantity": "866 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01920, Exp. Date, 12/31/2025, N02023, Exp. Date, 02/28/2026 & N02202, Exp. Date, 06/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-030", "70069-031", "70069-381", "70069-382", "70069-383", "70069-384"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859867", "859871", "1719803", "1719862"], "spl_id": ["f6d888a0-65a7-4073-8671-b00b4bfaff4c"], "spl_set_id": ["f2bff27f-929f-4f7d-b3eb-084ebc2a885f"], "package_ndc": ["70069-030-05", "70069-030-03", "70069-031-01", "70069-031-05", "70069-381-01", "70069-381-10", "70069-382-01", "70069-382-05", "70069-383-05", "70069-383-10", "70069-383-01", "70069-384-01", "70069-384-05"], "is_original_packager": [true], "upc": ["0370069382011", "0370069383018", "0370069031018", "0370069030011", "0370069384015"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0355-2025", "product_description": "Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-381-01 (individual carton) and NDC 70069-381-10 (10x1 mL carton)", "product_quantity": "997 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "NDC 70069-381-01; A240467A, exp. date 07/2026;  NDC 70069-381-10; A240467C, exp. date 07/2026"}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["MEDLINE ALCOHOL PREP"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-811"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["41483c3f-f207-027f-e063-6394a90aea68"], "spl_set_id": ["c9fae7b6-2f4b-490b-9b17-a7297e738069"], "package_ndc": ["53329-811-30", "53329-811-09", "6122404005"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97385", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0600-2025", "product_description": "Medline Alcohol Prep Pads, 70% Isopropyl Alcohol, 100 Sterile 2-Ply Pads, Single Use Only, Large, www.medline.com, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, 1-800-MEDLINE, NDC 53329-811-30.", "product_quantity": "6669874 swabs", "reason_for_recall": "Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.", "recall_initiation_date": "20250707", "center_classification_date": "20250826", "report_date": "20250903", "code_info": "61224040057", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205006"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "product_ndc": ["68462-678", "68462-679", "68462-680", "68462-681"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_id": ["a65056ce-b6e9-4bed-adbd-98052a2e705e"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "package_ndc": ["68462-678-30", "68462-678-60", "68462-678-10", "68462-679-30", "68462-679-60", "68462-679-10", "68462-680-30", "68462-680-60", "68462-680-10", "68462-681-30", "68462-681-60", "68462-681-10"], "is_original_packager": [true], "upc": ["0368462680605", "0368462681602"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0321-2025", "product_description": "Lacosamide Tablets 200mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-681-60.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17230982, exp. date Apr-25 17230986, exp. date, Apr-25 17231001, exp. date, Apr-25 17240197, exp. date Jan-26 17240198, exp. date Jan-26 17240215, exp. date Jan-26 17240846, exp. date Apr-26 17240847, exp. date Apr-26"}, {"status": "Ongoing", "city": "Lakewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96792", "recalling_firm": "BSO LLC", "address_1": "12860 W Cedar Dr Ste 211", "address_2": "N/A", "postal_code": "80228-1971", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0416-2025", "product_description": "TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01", "product_quantity": "1,964 vials", "reason_for_recall": "Presence of Particulate Matter: Glass particles were found in pellet vials.", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot 20250129@1, exp 1/17/2026; Lot 20250218@4, exp 1/25/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0197-2025", "product_description": "Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8028-1.", "product_quantity": "7198 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDC0124001A Exp 09/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0667-2025", "product_description": "Micronized BPO Gel Cleanser 10% (Benzoyl Peroxide 10%) Pantea MD , 7 oz (201 g), University Skin Institute, 650 University Ave, Ste 200, Sacramento, CA 95825.", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97364", "recalling_firm": "PFIZER INC", "address_1": "68 Hudson Blvd E", "address_2": "N/A", "postal_code": "10001-2188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0591-2025", "product_description": "Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24.  Case NDC: 00409-6637-14.", "product_quantity": "15,750 vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20250804", "center_classification_date": "20250818", "report_date": "20250827", "code_info": "Lot #: LH2671, Exp. 11/30/2026"}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96307", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0272-2025", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, 855-275-2270, NDC 71285-6092-1.", "product_quantity": "1546 bags", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20250220", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot 37-928390, Exp Date, 03MAR2025; Lot 37-928796, Exp Date, 09MAR2025; Lot 37-928839, Exp Date, 10MAR2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090858"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6665", "0904-6666", "0904-6667"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["b6880b32-3ebc-4b0e-8a84-d513f3e401af"], "spl_set_id": ["36f74fdf-0dae-47a0-a7ea-e64ac91cd88f"], "package_ndc": ["0904-6665-61", "0904-6666-61", "0904-6667-61"], "original_packager_product_ndc": ["67877-222", "67877-223", "67877-224"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "97777", "recalling_firm": "The Harvard Drug Group LLC", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "US Nationwide.", "recall_number": "D-0030-2026", "product_description": "Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .", "recall_initiation_date": "20251010", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # M04950, Exp Date: 01/2026; Lot # M04989, M04990, Exp Date: 02/2026; Lot # M05056, Exp Date: 04/2026; Lot # M05150, Exp Date: 07/2026; Lot # M05290, Exp Date: 11/2026; Lot # M05312, M05342, Exp Date: 01/2027; Lot # M05369, M05386, Exp Date: 02/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216350"], "brand_name": ["FLUPHENAZINE HYDROCHLORIDE"], "generic_name": ["FLUPHENAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-336", "68462-914", "68462-337", "68462-338"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUPHENAZINE HYDROCHLORIDE"], "rxcui": ["859841", "860918", "865117", "865123"], "spl_id": ["a0534178-2ffc-4beb-adf2-00a2f2d246c4"], "spl_set_id": ["4c3eea71-a7a1-4eda-9871-034ddeb83ed6"], "package_ndc": ["68462-914-01", "68462-914-05", "68462-914-14", "68462-336-01", "68462-336-05", "68462-336-14", "68462-337-01", "68462-337-05", "68462-337-14", "68462-338-01", "68462-338-05", "68462-338-14"], "is_original_packager": [true], "upc": ["0368462338018", "0368462337011", "0368462914144"], "unii": ["ZOU145W1XL"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0326-2025", "product_description": "Fluphenazine Hydrochloride Tablets, 10mg, 100-Count Bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-338-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232206, exp. date Sep-25"}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["43063-877"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596930"], "spl_id": ["3285a9f3-82fd-8b46-e063-6294a90ab809"], "spl_set_id": ["696a345f-d70c-4ce8-94f7-a8a21f2d20f0"], "package_ndc": ["43063-877-90"], "original_packager_product_ndc": ["57237-018"], "upc": ["0343063877906"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95922", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed within US: FL, MS, WI", "recall_number": "D-0163-2025", "product_description": "DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90", "product_quantity": "70, 90-count bottles", "reason_for_recall": "CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit", "recall_initiation_date": "20241204", "center_classification_date": "20241223", "termination_date": "20250321", "report_date": "20250101", "code_info": "Lot # I24E77, A24E49, Exp Date: 04/30/25;  J23C50, J23C97, L23B39, L23E98, Exp Date: 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209467"], "brand_name": ["SUCCINYLCHOLINE CHLORIDE"], "generic_name": ["SUCCINYLCHOLINE CHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1377"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["SUCCINYLCHOLINE CHLORIDE"], "rxcui": ["1594589"], "spl_id": ["bd190da3-9daf-4859-a431-87c693e18e90"], "spl_set_id": ["017e5ad4-028e-4e34-ac09-d0c8d64c880a"], "package_ndc": ["70710-1377-1", "70710-1377-2"], "is_original_packager": [true], "unii": ["I9L0DDD30I"]}, "product_type": "Drugs", "event_id": "97510", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, OH, LA, and Puerto Rico", "recall_number": "D-0623-2025", "product_description": "Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton).", "product_quantity": "270,125 Vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.", "recall_initiation_date": "20250827", "center_classification_date": "20250908", "report_date": "20250917", "code_info": "Lot #s: L400077, exp: 8/31/2025; L400113, exp.: 9/30/2025; L400372, L400373, exp.: 3/31/2026; L400374, exp.: 4/30/2026."}, {"status": "Ongoing", "city": "Naples", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209294"], "brand_name": ["CLOMIPRAMINE HYDROCHLORIDE"], "generic_name": ["CLOMIPRAMINE HYDROCHLORIDE CAPSULES"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-492", "68180-493", "68180-494"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOMIPRAMINE HYDROCHLORIDE"], "rxcui": ["857297", "857301", "857305"], "spl_id": ["7e89336a-0de0-42d6-af70-26345940b81d"], "spl_set_id": ["ebad19b5-e5dd-4f77-ab97-d20ce0f24cb9"], "package_ndc": ["68180-492-01", "68180-492-07", "68180-492-09", "68180-492-06", "68180-493-01", "68180-493-07", "68180-493-09", "68180-493-06", "68180-494-01", "68180-494-07", "68180-494-09", "68180-494-06"], "is_original_packager": [true], "upc": ["0368180494065", "0368180493068"], "unii": ["2LXW0L6GWJ"]}, "product_type": "Drugs", "event_id": "96681", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "5801 Pelican Bay Blvd", "address_2": "Suite 500", "postal_code": "34108-2755", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0377-2025", "product_description": "clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, United States, Manufactured By: Lupin Limited, Nagpur, 441 108 INDIA, NDC 68180-492-01", "product_quantity": "2724 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.", "recall_initiation_date": "20250410", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #: M300442, Exp Date: 6/30/2025"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0237-2025", "product_description": "Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-271-30.", "product_quantity": "39,168 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers:  19234955, 19234956, Exp.: 11/2025; 19240971, Exp.: 2/2026; 19241864, Exp.: 4/2026."}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0524-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-456-17", "product_quantity": "2,344 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300042, Exp Date: 12/31/2025"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0242-2025", "product_description": "Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-759-01.", "product_quantity": "53,952 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234630, Exp.: 10/2025; 19240529, Exp.: 1/2026."}, {"status": "Ongoing", "city": "Clark", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96390", "recalling_firm": "L'Oreal USA", "address_1": "222 Terminal Ave", "address_2": "", "postal_code": "07066-1317", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0417-2025", "product_description": "La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.", "product_quantity": "2,226,801 bottles", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.", "recall_initiation_date": "20250305", "center_classification_date": "20250509", "report_date": "20250521", "code_info": "Lot #: MYX46W, Exp 04/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021163"], "brand_name": ["INFUVITE ADULT"], "generic_name": ["MULTIPLE VITAMINS INJECTION"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["54643-5649", "54643-5650"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["1304559", "1304564"], "spl_id": ["5cd4a682-f5e5-42fe-9151-8ecc77fe7464"], "spl_set_id": ["14c7bfc5-07e8-400f-b8ff-5e4794dd2805"], "package_ndc": ["54643-5649-1", "54643-5657-1", "54643-5659-1", "54643-5650-2", "54643-5661-2", "54643-5663-2"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "96744", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Distributed to Medical Facilities in MS and FL.", "recall_number": "D-0401-2025", "product_description": "Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only, Sterile, Manufactured for: Sandoz Inc., Princeton, NJ 08540, Distributed by Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product of Canada, NDC 54643-5649-1", "product_quantity": "15", "reason_for_recall": "Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025.   The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.", "recall_initiation_date": "20250425", "center_classification_date": "20250501", "report_date": "20250507", "code_info": "Lot #: AA2279, Exp 8/31/26; AA2383, Exp 9/30/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208994"], "brand_name": ["KIT FOR THE PREPARATION OF TECHNETIUM TC99M MERTIATIDE"], "generic_name": ["BETIATIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["45567-0655"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["BETIATIDE"], "spl_id": ["21ca1be3-2caf-535c-e063-6394a90a18e5"], "spl_set_id": ["0ad62039-f848-4f3d-b489-2524e6b6b86e"], "package_ndc": ["45567-0655-1"], "is_original_packager": [true], "unii": ["9NV2SR34P8"]}, "product_type": "Drugs", "event_id": "97460", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0658-2025", "product_description": "Kit for the Preparation of Technetium Tc 99m Mertiatide, Rx Only, Manufactured by: Sun Pharmaceutical Industries, Inc. Billerica, MA 01821, NDC 45567-0655-1", "product_quantity": "1870 kits", "reason_for_recall": "Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.", "recall_initiation_date": "20250903", "center_classification_date": "20250922", "report_date": "20250924", "code_info": "Lot# AD70995; Exp 10/31/2025"}, {"status": "Ongoing", "city": "Nogales", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96914", "recalling_firm": "Umary-USA.com", "address_1": "243 W Crawford St", "address_2": "STE 40026", "postal_code": "85621-3208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide via internet.", "recall_number": "D-0493-2025", "product_description": "UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134", "product_quantity": "1,704 30-count bottles", "reason_for_recall": "Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.", "recall_initiation_date": "20250521", "center_classification_date": "20250624", "report_date": "20250625", "code_info": "All Lots; All Expiration Dates.", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-271", "65162-272"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198334", "198335"], "spl_id": ["6cbe0ea0-5ed0-4941-ad3c-4396a56fdfc6"], "spl_set_id": ["f0e73842-6002-43c2-97fc-0cadc1bf6346"], "package_ndc": ["65162-271-05", "65162-271-10", "65162-271-50", "65162-271-11", "65162-272-01", "65162-272-24", "65162-272-10", "65162-272-25", "65162-272-50"], "is_original_packager": [true], "upc": ["0365162271102", "0365162272109"], "nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["JE42381TNV", "AN164J8Y0X"]}, "product_type": "Drugs", "event_id": "96985", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0488-2025", "product_description": "Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, Rx Only, a) 100 Tablets per Bottle, NDC: 65162-271-10, b) 500 Tablets per Bottle, NDC: 65162-271-50, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.", "product_quantity": "6396 bottles", "reason_for_recall": "Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.", "recall_initiation_date": "20250602", "center_classification_date": "20250623", "report_date": "20250618", "code_info": "Lot #s: a) AM241019, AM241020, Exp. 06/30/2027 b) AM241019A, Exp 06/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95777", "recalling_firm": "MXBBB", "address_1": "1162 Tio Dink Cir", "address_2": "", "postal_code": "79907-1912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was sold via Amazon Marketplace.", "recall_number": "D-0166-2025", "product_description": "UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323", "product_quantity": "321 bottles", "reason_for_recall": "cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.", "recall_initiation_date": "20241114", "center_classification_date": "20241226", "report_date": "20250101", "code_info": "Lot#: 24183, Exp 07/01/28", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0522-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17", "product_quantity": "4,896 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300104, Exp Date: 12/31/2025"}, {"status": "Ongoing", "city": "Benton", "state": "AR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96328", "recalling_firm": "One Source Nutrition, Inc,", "address_1": "19863 Interstate 30 S", "address_2": "N/A", "postal_code": "72015-6966", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0281-2025", "product_description": "Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme Potency.", "product_quantity": "a) 300 individually wrapped capsules b) 20 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.", "recall_initiation_date": "20250220", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "All lots"}, {"status": "Ongoing", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761043"], "brand_name": ["BENLYSTA"], "generic_name": ["BELIMUMAB"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["49401-088", "49401-102", "49401-101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["BELIMUMAB"], "rxcui": ["1656395", "1656398", "1656400", "1656402", "1939296", "1939299", "1939346", "1939348"], "spl_id": ["11b07c42-5e17-47bb-94f0-03a520420b96"], "spl_set_id": ["2fa3c528-1777-4628-8a55-a69dae2381a3"], "package_ndc": ["49401-102-01", "49401-101-01", "49401-088-42", "49401-088-47", "49401-088-50", "49401-088-01", "49401-088-35", "49401-088-02", "49401-088-61"], "is_original_packager": [true], "nui": ["N0000182156", "N0000182637", "N0000182636"], "pharm_class_pe": ["Decreased B Lymphocyte Activation [PE]"], "pharm_class_epc": ["B Lymphocyte Stimulator-specific Inhibitor [EPC]"], "pharm_class_moa": ["B Lymphocyte Stimulator-directed Antibody Interactions [MoA]"], "unii": ["73B0K5S26A"]}, "product_type": "Drugs", "event_id": "97110", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the U.S - OH, VA, FL.", "recall_number": "D-0540-2025", "product_description": "BENLYSTA  (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.", "product_quantity": "3 Vials", "reason_for_recall": "CGMP Deviations; potential temperature excursions due to transit delays", "recall_initiation_date": "20250421", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot: YK4W, Expiration date: 4/30/2029"}, {"status": "Ongoing", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96290", "recalling_firm": "Ascent Consumer Products Inc.", "address_1": "105 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3833", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0300-2025", "product_description": "SinuCleanse Premixed SALINE PACKETS (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg) for Nasal Wash System, 60-count All Natural USP Grade Saline Packets, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00103 4", "product_quantity": "unknown", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus", "recall_initiation_date": "20250128", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot# 024122661Al, Exp Date 12/2027"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0636-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.  NDC: 70710-1132-1", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z305079, Z305080, Exp Date 30-09-25; Z305454, Z305455, Z305457, Z400492,  Z400493, Z400494, Exp Date 31-12-25; Z401158, Z401725, Z401726, Exp. Date 28-02-26; Z404118, Z404119, Z404120, Exp Date 30-06-26; Z405648, Exp Date 30-09-26"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96074", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0190-2025", "product_description": "Duloxetine DR Capsules USP 60  mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ", "product_quantity": "244,460 bottles", "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "Lot # a) DT6023053A, DT6023061A, DT6023068A, DT6023074A, exp. date Jan-25;  DT6023078A, DT6023076A, exp. date Feb-25;  DTC24043A, DTC24044A, exp. date Dec-25   b) DT6023002A, DT6023016A, DT6023036A, exp. date Dec-24;  DT6023048A, exp. date Jan-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205932"], "brand_name": ["PITAVASTATIN"], "generic_name": ["PITAVASTATIN CALCIUM"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-905", "42291-906", "42291-907"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PITAVASTATIN CALCIUM"], "rxcui": ["861643", "861648", "861652"], "spl_id": ["0f1207f0-5d7c-5aa6-e063-6394a90ab854"], "spl_set_id": ["0f11ee80-871e-4f13-e063-6394a90af19d"], "package_ndc": ["42291-906-90", "42291-907-90", "42291-905-90"], "original_packager_product_ndc": ["0480-3632", "0480-3633", "0480-3631"], "unii": ["IYD54XEG3W"]}, "product_type": "Drugs", "event_id": "97160", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0529-2025", "product_description": "Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478.  NDC: 42291-906-90", "product_quantity": "8,573 bottles", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20250626", "center_classification_date": "20250716", "report_date": "20250709", "code_info": "Lot, expiry:  Lot 46211, exp 10/31/2025; Lot 47683, exp 05/31/2026; Lot 46944 , exp 01/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Chambersburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97688", "recalling_firm": "Acuity Specialty Products, Inc.", "address_1": "800 Development Ave", "address_2": "", "postal_code": "17201-4103", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0004-2026", "product_description": "Wyandotte, Sanifect E3, Hand Sanitizer (Ethanol-Based, Product 5511), Ethyl Alcohol 60.1%, Manufacture By: AFCO, 550 Development Avenue, Chambersburg, PA 17210, Toll Free: 800-345-1329, Package Configurations: a) 6x1000mL Case, b) 4x1 Gallon Case, c) 5 Gallon Pail, d) 55 Gallon Drum.", "product_quantity": "", "reason_for_recall": "cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.", "recall_initiation_date": "20250929", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # C2427010, Exp 9/26/2025; Lot # C2432621, Exp 11/21/2025; Lot # C2501514, Exp 1/15/2026; Lot # C2508606, Exp 3/27/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074086"], "brand_name": ["DOBUTAMINE"], "generic_name": ["DOBUTAMINE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-2344"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOBUTAMINE HYDROCHLORIDE"], "rxcui": ["1812168"], "spl_id": ["e71e9520-871b-479d-9652-1857fceca863"], "spl_set_id": ["dc537761-d5f4-488d-24ab-b2bcd2b17b7a"], "package_ndc": ["0409-2344-01", "0409-2344-62", "0409-2344-02"], "is_original_packager": [true], "unii": ["0WR771DJXV"]}, "product_type": "Drugs", "event_id": "96947", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0489-2025", "product_description": "DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.  NDC Carton:  0409-2344-02; NDC Vial: 0409-2344-62", "product_quantity": "98,410 vials", "reason_for_recall": "Discoloration; discolored solution from cracked vials", "recall_initiation_date": "20250528", "center_classification_date": "20250623", "report_date": "20250702", "code_info": "Lot KA5023, exp 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96582", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0308-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per bottle, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical, Inc., Berkley Heights, NJ 07922, NDC 51991-747-10.", "product_quantity": "14,863 bottles", "reason_for_recall": "CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.", "recall_initiation_date": "20250326", "center_classification_date": "20250401", "report_date": "20250409", "code_info": "Lot 240909C, Exp Date 03/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Cremorne", "state": "N/A", "country": "Australia", "classification": "Class II", "openfda": {"application_number": ["M020"], "brand_name": ["ULTRA VIOLETTE VELVET SCREEN BLURRING MINERAL SKINSCREEN"], "generic_name": ["SPF50"], "manufacturer_name": ["Grace And Fire USA Inc."], "product_ndc": ["84803-106"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ZINC OXIDE"], "spl_id": ["275c5140-634d-9012-e063-6394a90a4945"], "spl_set_id": ["275c76f4-e5c5-ca4f-e063-6294a90a6519"], "package_ndc": ["84803-106-02", "84803-106-01", "9355909006", "9355909005"], "is_original_packager": [true], "unii": ["SOI2LOH54Z"]}, "product_type": "Drugs", "event_id": "97498", "recalling_firm": "GRACE & FIRE PTY LTD", "address_1": "19 Dover Street", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0640-2025", "product_description": "Ultra Violette, Velvet Screen SPF 50, Blurring Mineral Skinscreen, Zinc Oxide 22.75%, a) 15 mL, 0.5 fl. oz. per tube, NDC 84803-106-01, UPC 9355909006068, b) 50 mL, 1.7 fl. oz. per tube, NDC 84803-106-02, UPC 9355909005924, Distributed by: Grace & Fire USA Inc., 251 Little Falls Drive, New Castle Wilmington, Delaware 19808.", "product_quantity": "49,275 tubes", "reason_for_recall": "Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.", "recall_initiation_date": "20250822", "center_classification_date": "20250911", "report_date": "20250917", "code_info": "Lot #s:  a) 15 mL tubes: A2455, exp 12/31/2026; b) 50 mL tubes: A2453A, A2453B, exp 11/30/2026; A2454A, exp 12/31/2026; A2550, exp 02/28/2027"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205268"], "brand_name": ["PROPAFENONE HYDROCHLORIDE"], "generic_name": ["PROPAFENONE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-825", "16714-826", "16714-827"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROPAFENONE HYDROCHLORIDE"], "rxcui": ["861156", "861164", "861171"], "spl_id": ["59aaf0aa-9074-4563-93ba-1c97e76352a2"], "spl_set_id": ["2ecd6452-ccc3-493f-9a4a-69f0fbf67a42"], "package_ndc": ["16714-825-01", "16714-826-01", "16714-827-01"], "is_original_packager": [true], "upc": ["0316714826011", "0316714827018", "0316714825014"], "unii": ["33XCH0HOCD"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0352-2025", "product_description": "Propafenone Hydrochloride Extended-Release Capsules, USP 325mg,60-count bottles, Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-826-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230767, exp. date Mar-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079172"], "brand_name": ["ROSUVASTATIN CALCIUM"], "generic_name": ["ROSUVASTATIN CALCIUM"], "manufacturer_name": ["Glenmark Pharmaceutials Inc., USA"], "product_ndc": ["68462-261", "68462-262", "68462-263", "68462-264"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROSUVASTATIN CALCIUM"], "rxcui": ["859419", "859424", "859747", "859751"], "spl_id": ["d7bce859-1f71-4b45-bf53-7c00ad9fbdb2"], "spl_set_id": ["392657a9-955c-42c2-814c-1890ece45afa"], "package_ndc": ["68462-261-30", "68462-261-50", "68462-261-90", "68462-261-01", "68462-261-10", "68462-261-11", "68462-262-30", "68462-262-50", "68462-262-90", "68462-262-01", "68462-262-10", "68462-262-11", "68462-263-30", "68462-263-50", "68462-263-90", "68462-263-01", "68462-263-10", "68462-263-11", "68462-264-30", "68462-264-50", "68462-264-90", "68462-264-01", "68462-264-05", "68462-264-10"], "is_original_packager": [true], "upc": ["0368462263907", "0368462262900"], "unii": ["83MVU38M7Q"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0339-2025", "product_description": "Rosuvastatin Tablets 40mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-264-30", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240389, exp. date Feb-26 17240390, exp. date Feb-26 17240426, exp. date Feb-26 17240427, exp. date Feb-26 17240428, exp. date Feb-26 17240778, exp. date Apr-26 17241055, exp. date May-26 17241074, exp. date  Jun-26 17241075, exp. date  Jun-26 17241091, exp. date  Jun-26 17241100, exp. date  Jun-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203501"], "brand_name": ["INDOMETHACIN"], "generic_name": ["INDOMETHACIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["INDOMETHACIN"], "rxcui": ["310992"], "spl_id": ["3e56ab33-0411-43c3-a97c-0139ec343d0d"], "spl_set_id": ["532d40b2-c05c-4d4f-b7ee-e6434c4c27fc"], "package_ndc": ["68462-325-60", "68462-325-90", "68462-325-01", "68462-325-05", "68462-325-10"], "is_original_packager": [true], "upc": ["0368462325605"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["XXE1CET956"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0329-2025", "product_description": "Indomethacin Extended-Release Capsules, 75mg, 60-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-325-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232323, exp. date Oct-25 17232335, exp. date Oct-25 17232323, exp. date Oct-25"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206937"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-443", "13668-473"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["2532159", "2532163"], "spl_id": ["f8d8c930-c8f9-4186-92fa-6f7a5dabe083"], "spl_set_id": ["dcebc7cf-6f95-4f7a-a22b-c7d2e0f04d74"], "package_ndc": ["13668-443-74", "13668-443-10", "13668-443-01", "13668-443-30", "13668-443-91", "13668-473-10", "13668-473-74", "13668-473-30", "13668-473-01", "13668-473-91"], "is_original_packager": [true], "upc": ["0313668443301", "0313668473308"], "unii": ["I9W7N6B1KJ"]}, "product_type": "Drugs", "event_id": "96983", "recalling_firm": "Torrent Pharma Inc.", "address_1": "106 Allen Rd Ste 305", "address_2": "N/A", "postal_code": "07920-3851", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0455-2025", "product_description": "Fluoxetine Tablets, USP, 20 mg,  30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920.  NDC: 13668-473-30", "product_quantity": "3672 Bottles", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.", "recall_initiation_date": "20250527", "center_classification_date": "20250602", "report_date": "20250611", "code_info": "Lot# BDX6K001; Exp. Date 06/30/2025"}, {"status": "Ongoing", "city": "Columbia", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96754", "recalling_firm": "Apollo Care, LLC", "address_1": "3801 Mojave Ct Ste 101", "address_2": "N/A", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MO", "recall_number": "D-0409-2025", "product_description": "FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% Sodium Chloride Injection (For Epidural Use Only), Sterile, Single-Use Container, Rx Only, Apollocare, 3801 Mojave Ct, Ste 101, Columbia, MO 65202, NDC 71170-950-25", "product_quantity": "440 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250415", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot AC-016878, exp date 6/16/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Tempe", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96735", "recalling_firm": "SAINI TRADE INC", "address_1": "1405 N Scottsdale Rd", "address_2": "", "postal_code": "85288-1714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0466-2025", "product_description": "ULTRA ARMOR, My Armor My Power, Dietary Supplement, 10 capsules per box, Distributed by Health Fixer, Tempe, AZ 85288, UPC B0CYJ7Y5H9.", "product_quantity": "500 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.", "recall_initiation_date": "20250414", "center_classification_date": "20250611", "report_date": "20250618", "code_info": "All lots Lot #: KT-1ST-43-01-10/2025, Exp. 01/10/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["POVIDONE-IODINE"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-939"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["312564"], "spl_id": ["129c8b5c-88ca-c276-e063-6294a90a993f"], "spl_set_id": ["c9036a83-22f5-4a09-b01c-7093d4192c19"], "package_ndc": ["53329-939-04", "53329-939-06", "53329-939-08", "53329-939-23", "53329-939-25", "53329-939-69", "53329-939-13"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "97486", "recalling_firm": "Medline Industries, LP", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0674-2025", "product_description": "READYPREP PVP, Povidone-Iodine 10% Solution, Topical Antiseptic, Not Sterile, 1 Gallon (3.78 L) per bottle, Manufactured in USA by Medline Industries, LP., Three Lakes Drive, Northfield, IL 60093, NDC 53329-939-25", "product_quantity": "2,680 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20250819", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 24EJA180, Exp 06/01/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-419", "60687-430", "60687-441", "60687-452", "60687-463"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["19336340-ad22-62b7-e063-6294a90affed"], "spl_set_id": ["d43718e5-66d7-44f9-9fc8-80d38d3e41ce"], "package_ndc": ["60687-419-11", "60687-419-01", "60687-430-11", "60687-430-01", "60687-430-65", "60687-441-11", "60687-441-01", "60687-452-11", "60687-452-01", "60687-463-11", "60687-463-01"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97533", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0647-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10) blisterpacks, NDC: 60687-430-01, (Individual Dose NDC: 60687-430-11), Rx Only,  Distributed by: American Health Packaging, Columbus, Ohio 43217.", "product_quantity": "2,708 cartons", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250827", "center_classification_date": "20250915", "report_date": "20250924", "code_info": "Lot:  a)1020919, 1021133, Exp 09/30/2026; 1021447, Exp 10/31/2026; 1021741, 1022202, Exp 11/30/2026; 1022474, Exp 12/31/2026  Lot: b) 1020460, exp 08/31/2026; 1022417, exp 12/31/2026"}, {"status": "Ongoing", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074453"], "brand_name": ["METOPROLOL TARTRATE"], "generic_name": ["METOPROLOL TARTRATE"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "product_ndc": ["69367-354", "69367-355"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL TARTRATE"], "rxcui": ["866511", "866514"], "spl_id": ["dfdf476e-ca66-4836-bc6e-1c8e035d95b0"], "spl_set_id": ["4d352c34-47f8-4662-9ac5-d5a32bd1660f"], "package_ndc": ["69367-354-10", "69367-354-01", "69367-355-10", "69367-355-01"], "is_original_packager": [true], "upc": ["0369367354103"], "unii": ["W5S57Y3A5L"]}, "product_type": "Drugs", "event_id": "97395", "recalling_firm": "Westminster Pharmaceuticals LLC", "address_1": "1321 Murfreesboro Pike Ste 607", "address_2": "N/A", "postal_code": "37217-2693", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0582-2025", "product_description": "Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-355-10", "product_quantity": "4,456 1000-count bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.", "recall_initiation_date": "20250806", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Batch # R56240011, Exp Date: 2/28/26; Batch # R56240021, R56240031, Exp Date: 3/31/26; Batch # R56240041, R56240051, R56240061, Exp Date: 4/30/26; Batch # R56240071, Exp Date: 7/31/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA019632"], "brand_name": ["LACTATED RINGERS"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CALCIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["847630"], "spl_id": ["ed789cd7-83ae-4ec1-a696-e87c1569da49"], "spl_set_id": ["f6d82772-638c-4584-b9d3-8833669f5963"], "package_ndc": ["0264-7750-07"], "is_original_packager": [true], "unii": ["M4I0D6VV5M", "660YQ98I10", "451W47IQ8X", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "97433", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0627-2025", "product_description": "Lactated Ringers's Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7750-07", "product_quantity": "46,032 containers", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20250818", "center_classification_date": "20250910", "report_date": "20250910", "code_info": "Lot #: J4S807, Exp 5/31/2027"}, {"status": "Ongoing", "city": "Easton", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M019"], "brand_name": ["POWER STICK INVISIBLE PROTECTION ROLL- ON ANTIPERSPIRANT DEODORANT SPRING FRESH"], "generic_name": ["ALUMINUM SESQUICHLOROHYDRATE"], "manufacturer_name": ["A.P. Deauville, LLC"], "product_ndc": ["42913-039"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALUMINUM SESQUICHLOROHYDRATE"], "spl_id": ["1d47eeb1-98de-35a8-e063-6394a90a4c34"], "spl_set_id": ["f6bb8e7f-01b8-4708-a533-bd143cd5a605"], "package_ndc": ["42913-039-00", "8151950181"], "is_original_packager": [true], "upc": ["0815195018194", "815195018194"], "unii": ["UCN889409V"]}, "product_type": "Drugs", "event_id": "97211", "recalling_firm": "A.P. Deauville, LLC", "address_1": "3700 Glover Rd", "address_2": "N/A", "postal_code": "18040-9285", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0549-2025", "product_description": "Beauty & Skincare Power Stick original nourishing  invisible protection roll-on Antiperspirant/Deodorant Spring Fresh, 1.8 oz./53 mL, A.P Deauville, LLC, PA 18040, NDC# 42913-039-00, UPC Code 815195018194", "product_quantity": "22,482 Cases", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250710", "center_classification_date": "20250731", "report_date": "20250723", "code_info": "Lot #  031726A991, 041226B561, 062026C901, 062026C911, 071026D351, 071026D361, 071326D391, 111626G231"}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0664-2025", "product_description": "Skin MD by Dr Monika Kiripolsky, Body Acne Cleanser (Benzoyl Peroxide 10%), 7 oz (201 g),  Monika Kiripolsky, MD Beverly Hills, CA, 90211", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}]